| 08th week of 2019 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20190054119 | MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS | 2019-02-21 |
| 20190054120 | COMPOSITIONS AND METHODS FOR ISOLATING AND ENRICHING IGM-PRODUCING CELLS AND USES THEREOF | 2019-02-21 |
| 20190054121 | COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE | 2019-02-21 |
| 20190054122 | INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY | 2019-02-21 |
| 20190054123 | CELL SHEET COMPOSITION INCLUDING MESENCHYMAL STEM CELLS, AND METHOD FOR HEALING LUMINAL ORGAN USING SAME | 2019-02-21 |
| 20190054124 | CELL POPULATION SEEDING IN DERMAL MATRICES FOR ENDOCRINE DISORDER MANAGEMENT | 2019-02-21 |
| 20190054125 | hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS | 2019-02-21 |
| 20190054126 | COMPOSITIONS AND METHODS FOR ENHANCING CANCER RADIOTHERAPY | 2019-02-21 |
| 20190054127 | ANTIVIRAL AGENT AND ANTIVIRAL FOOD | 2019-02-21 |
| 20190054128 | VAGINAL PREPARATIONS FOR MAINTAINING AND/OR RESTORING HEALTHY FEMALE MICROBIOTA | 2019-02-21 |
| 20190054129 | REDUCING CONJUGATIVE PLASMIDS IN BACTERIA | 2019-02-21 |
| 20190054130 | TREATMENT METHODS USING ADENOVIRUS | 2019-02-21 |
| 20190054131 | REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF THYMIDINE KINASE WITH AND WITHOUT THE EXPRESSION OF HUMAN FLT3L OR GM-CSF FOR CANCER IMMUNOTHERAPY | 2019-02-21 |
| 20190054132 | CHINESE MEDICINE COMPOSITION FOR TREATING LEUKEMIA BONE MARROW TRANSPLANT FAILURE COMPLICATED BY BRAIN STEM STROKE AFTER CHEMOTHERAPY | 2019-02-21 |
| 20190054133 | METHOD FOR INCREASING EXPRESSIONS OF CLOCK GENE, ARNTL GENE, AND/OR PER2 GENE BY USING MOMORDICA CHARANTIA EXTRACT | 2019-02-21 |
| 20190054134 | WHOLE GREEN COFFEE BEAN PRODUCTS AND METHODS OF PRODUCTION AND USE FOR PREVENTING OR TREATING OBESITY AND DIABETES | 2019-02-21 |
| 20190054135 | PLANT OR MICROORGANISM-DERIVED CAROTENOID-OXYGEN COPOLYMER COMPOSITIONS, METHODS OF IDENTIFYING, QUANTIFYING AND PRODUCING SAME AND USES THEREOF | 2019-02-21 |
| 20190054136 | Dietary Supplement for the Treatment of Acid Reflux and Gastro-Oesophageal Reflux Disease (GORD/GERD) | 2019-02-21 |
| 20190054137 | PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2019-02-21 |
| 20190054138 | METHODS AND COMPOSITIONS FOR MODULATING HGF/MET | 2019-02-21 |
| 20190054139 | COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNE SYSTEM | 2019-02-21 |
| 20190054140 | BACTERICIDAL PEPTIDES AND USES THEREOF | 2019-02-21 |
| 20190054141 | MOLECULAR MARKER FOR CANCER STEM CELL | 2019-02-21 |
| 20190054142 | ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA | 2019-02-21 |
| 20190054143 | ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE | 2019-02-21 |
| 20190054144 | PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC STROKE AND METHOD THEREOF | 2019-02-21 |
| 20190054145 | SYNERGISTIC TUMOR TREATMENT WITH IL-2, AN INTEGRIN-BINDING-FC FUSION PROTEIN, AND A CANCER VACCINE | 2019-02-21 |
| 20190054146 | PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS | 2019-02-21 |
| 20190054147 | COMPOSITIONS AND METHODS FOR TREATMENT OF PEDIATRIC PAIN | 2019-02-21 |
| 20190054148 | NOVEL CELL MEMBRANE-PERMEATING PEPTIDE | 2019-02-21 |
| 20190054149 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST HUMAN INSULIN A21G AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION | 2019-02-21 |
| 20190054150 | MELANOCORTINS AND METHODS OF USE THEREOF | 2019-02-21 |
| 20190054151 | SYNTHETIC PLATELETS | 2019-02-21 |
| 20190054152 | Composition and Nutritional Supplement Made Therefrom | 2019-02-21 |
| 20190054153 | SIALYLATED GLYCOPROTEIN COMPOSITIONS AND USES THEREOF | 2019-02-21 |
| 20190054154 | TARGETING OF GLYCOPROTEIN THERAPEUTICS | 2019-02-21 |
| 20190054155 | Enzymes And Methods For Cleaving N-Glycans From Glycoproteins | 2019-02-21 |
| 20190054156 | Stabilized Thrombin | 2019-02-21 |
| 20190054157 | COMPOSITION AND METHOD OF PREPARATION OF PROTEASE MICROPARTICULATE SLOW RELEASE PREPARATION | 2019-02-21 |
| 20190054158 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY | 2019-02-21 |
| 20190054159 | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, PROCESS FOR ITS PREPARATION, AND ITS USE | 2019-02-21 |
| 20190054160 | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | 2019-02-21 |
| 20190054161 | INACTIVATED VACCINE FOR CHIKUNGUNYA VIRUS | 2019-02-21 |
| 20190054162 | INFLUENZA VACCINE | 2019-02-21 |
| 20190054163 | NOVEL INFLUENZA ANTIGENS | 2019-02-21 |
| 20190054164 | VACCINATION IN NEWBORNS AND INFANTS | 2019-02-21 |
| 20190054165 | COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN INFANTS OR YOUNG CHILDREN TO PREVENT OR TREAT ALLERGIES | 2019-02-21 |
| 20190054166 | NANOPARTICLES, CONTROLLED-RELEASE DOSAGE FORMS, AND METHODS FOR DELIVERING AN IMMUNOTHERAPEUTIC AGENT | 2019-02-21 |
| 20190054167 | METHOD FOR TREATING RHEUMATOID ARTHRITIS WITH A HUMAN IL-6 RECEPTOR ANTIBODY AND METHOTREXATE | 2019-02-21 |
| 20190054168 | IMMUNOGENIC PEPTIDE COMPOSITION AND METHOD | 2019-02-21 |
| 20190054169 | STABLE ANTI-OSMR ANTIBODY FORMULATION | 2019-02-21 |
| 20190054171 | FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS | 2019-02-21 |
| 20190054172 | SYSTEM FOR THERMOTHERAPY TREATMENT OR PREVENTION OF ANTIMICROBIAL RESISTANT OR BIOFILM INFECTIONS | 2019-02-21 |
| 20190054173 | COMPOSITIONS FOR PHOTODYNAMIC THERAPY AND FLUORESCENCE DIAGNOSIS OF CANCERS AND OTHER DISEASES | 2019-02-21 |
| 20190054174 | NANOPARTICLES OF INDIRUBIN, DERIVATIVES THEREOF AND METHODS OF MAKING AND USING SAME | 2019-02-21 |
| 20190054175 | EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING | 2019-02-21 |
| 20190054176 | COMPOSITIONS OF THERAPEUTIC SUBSTANCES, METHODS AND USES THEREOF | 2019-02-21 |
| 20190054177 | PEPTIDE SLOW-RELEASE FORMULATIONS | 2019-02-21 |
| 20190054178 | PHARMACEUTICAL COMPOSITION AND METHODS OF USES | 2019-02-21 |
| 20190054179 | NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | 2019-02-21 |
| 20190054180 | GENE/CARRIER COMPLEX FOR PREVENTING OR TREATING INFLAMMATORY DISEASES | 2019-02-21 |
| 20190054181 | FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS | 2019-02-21 |
| 20190054182 | TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION | 2019-02-21 |
| 20190054183 | Compositions and Methods for Targeted Delivery of Therapeutic and/or Diagnostic Agents | 2019-02-21 |
| 20190054184 | Targeting Macrophages to Modulate Electrical Conduction in the Heart | 2019-02-21 |
| 20190054185 | USE OF NANO-SIZED CLAY CRYSTALLITES TO RESTORE ADHESION AMONG TUMOR AND AGING STEM CELLS | 2019-02-21 |
| 20190054186 | Magnetic Nanoparticle-Polymer Complexes and uses Thereof | 2019-02-21 |
| 20190054187 | DRUG DELIVERY POLYMERS AND USES THEREOF | 2019-02-21 |
| 20190054188 | ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR | 2019-02-21 |
| 20190054189 | RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES | 2019-02-21 |
| 20190054190 | METHODS FOR THE TREATMENT OF DANON DISEASE AND OTHER DISORDERS OF AUTOPHAGY | 2019-02-21 |
| 20190054191 | SYNP161, A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN ROD PHOTORECEPTORS | 2019-02-21 |
| 20190054192 | ISOLATION OF EXTRACELLULAR VESICLES (EVs) FROM RED BLOOD CELLS FOR GENE THERAPY | 2019-02-21 |
| 20190054193 | ACTIVITY BASED PROBE AND USES THEREOF FOR IMAGING | 2019-02-21 |
| 20190054194 | System and Method For Evaluation of Subjects Using Magnetic Resonance Imaging and Oxygen-17 | 2019-02-21 |
| 20190054195 | MIRNA PROFILING COMPOSITIONS AND METHODS OF USE | 2019-02-21 |
| 20190054196 | MRI AND CT CONTRAST-ENABLED COMPOSITE IMPLANTS FOR IMAGE-GUIDED TISSUE REGENERATION AND THERAPY | 2019-02-21 |
| 20190054197 | RADIOLABELED MACROCYCLIC EGFR INHIBITOR | 2019-02-21 |
| 20190054198 | CATALYTIC RADIOFLUORINATION | 2019-02-21 |
| 20190054199 | GAS DELIVERY SYSTEM AND METHOD OF SANITIZING THE GAS FLOW PATH WITHIN A GAS DELIVERY SYSTEM | 2019-02-21 |
| 20190054200 | HOUSEHOLD PRODUCT DELIVERING WARMING AND/OR TINGLING SENSATIONS | 2019-02-21 |
| 20190054201 | FLOWING FLUID DISINFECTION METHOD AND DISINFECTOR | 2019-02-21 |
| 20190054202 | ANTI-MICROBIAL ARTICLES AND METHODS OF USING SAME | 2019-02-21 |
| 20190054203 | HEMOSTATIC MIXTURE OF CELLULOSE-BASED SHORT AND LONG FIBERS | 2019-02-21 |
| 20190054204 | PHOTOCROSSLINKED POLYMERS FOR ENHANCED DURABILITY | 2019-02-21 |
| 20190054205 | BIOPOLYMER COMPOSITIONS, SCAFFOLDS AND DEVICES | 2019-02-21 |
| 20190054206 | BIOACTIVE AGENT SPATIAL PATTERNED BIODEGRADABLE HYDROGELS | 2019-02-21 |
| 20190054207 | HYDROGELS WITH DYNAMICALLY ADJUSTABLE MECHANICAL PROPERTIES | 2019-02-21 |
| 20190054208 | COLLAGEN-BASED MENISCUS IMPLANTS | 2019-02-21 |
| 20190054209 | ARTIFICAL CORNEA STROMA MATERIAL, AND ARTIFICAL CORNEA STROMA AND ARTIFICAL CORNEA SCAFFOLD OF SUCH MATERIAL | 2019-02-21 |
| 20190054210 | PRODUCING BONE TISSUE ENGINEERED CONSTRUCTS | 2019-02-21 |
| 20190054211 | INTERPENETRATING POLYMER NETWORK HYDROGEL | 2019-02-21 |
| 20190054212 | CORE-CENTERED GRANULE COMPOSED OF MICRO-STRUCTURE BODY | 2019-02-21 |
| 20190054213 | Antimicrobial Medical Devices | 2019-02-21 |
| 20190054214 | Laser Markable Medical Devices | 2019-02-21 |
| 20190054215 | ARTIFICIAL CORNEAL STENT, AND ARTIFICIAL CORNEAL STROMA AND METHOD OF MAKING THE SAME | 2019-02-21 |
| 20190054216 | METHOD FOR LYMPHOLOGICAL LIPOSCULPTURE | 2019-02-21 |
| 20190054217 | Device For Collection Of Tissue And Method Of Use | 2019-02-21 |
| 20190054218 | Manually Activated Negative Pressure Therapy System With Integrated Audible Feedback | 2019-02-21 |
| 20190054219 | Systems And Methods For Controlling Inflammatory Response | 2019-02-21 |
